CLINICAL_TRIALS
trial_result
· 2016-10-31
Clinical Trial Update: TPI 287 in Patients With Recurrent Glioblastoma Multiforme [Phase 2]
Summary
Phase 2 trial of TPI-287 for recurrent glioblastoma multiforme was terminated; results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Brain Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-10-31